Adjuvax
Biotechnology Research • 
Birmingham, Alabama, United States • 1-10 Employees
Company overview
| Headquarters | 2000 9th Ave S, Station 41, Birmingham, Alabama 35205, US |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
| Socials |
Key Contact at Adjuvax
Victoria Hyunjung Kim
Vice President of R&D
Adjuvax Email Formats
Adjuvax uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@adjuvax.net), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@adjuvax.net | 100% |
About Adjuvax
Adjuvax focuses on developing potent new vaccine adjuvants, which are a crucial component of modern vaccines that enhance vaccines' efficacy. Adjuvax’s innovative technology opens the door to a significant expansion of the adjuvant toolbox by introducing structurally defined and easily accessible saponin adjuvants.
Adjuvax revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Adjuvax has never raised funding before.
Adjuvax Tech Stack
Discover the technologies and tools that power Adjuvax's digital infrastructure, from frameworks to analytics platforms.
CDN
PaaS
Static site generator
Miscellaneous
Miscellaneous
CDN
Sweden
India
United Kingdom
Frequently asked questions
4.8
40,000 users
